BioElectronics Corporation (BIEL)

0.0002 +0.0001 (+50.00%) At close: 03:54PM EDT

BioElectronics Corporation

4539 Metropolitan Court
Frederick, MD 21704
United States
301 874 4890
https://www.bielcorp.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Andrew J. Whelan	Founder	150k	N/A	1942
Ms. Kelly A. Whelan	CEO, President, Treasurer & Executive Director	N/A	N/A	N/A
Mr. Keith E. Nalepka	VP of Sales & Marketing and Executive Director	N/A	N/A	1974
John R. Martinez	Secretary & VP of Engineering	N/A	N/A	N/A

Amounts are as of 31 December 2009, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

BioElectronics Corporation, an electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide. Its products include ActiPatch, a musculoskeletal pain therapy; Allay, a menstrual pain therapy; and Smart Insole, a heel pain therapy. The company also offers RecoveryRx, a medical device that provides pain management therapy for medical professionals; and HealFast, a drug-free therapy for horses, cats, and dogs that reduces swelling and pain, as well as heals muscle and tendon injuries, sores, and incisions. It sells its products to wholesale distributors, hospitals and clinics, and consumers. The company was incorporated in 2000 and is headquartered in Frederick, Maryland.

Corporate governance

BioElectronics Corporation’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.